Longitudinal Spinal Cord Atrophy in Patients With Neuromyelitis Optica Spectrum Disorder and Its Association With Rituximab Treatment
Open Access
- 23 June 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (12) , e218120
Abstract
Background and ObjectivesLongitudinally extensive transverse myelitis (LETM) is a core feature of neuromyelitis optica spectrum disorder (NMOSD), which leads to spinal cord atrophy. We aim to deter...Keywords
This publication has 37 references indexed in Scilit:
- Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple SclerosisJAMA Neurology, 2022
- Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI dataRevue Neurologique, 2021
- Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenuesThe Lancet Neurology, 2020
- MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practiceNature Reviews Neurology, 2020
- Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersThe Lancet Neurology, 2019
- SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI dataNeuroImage, 2017
- Spinal cord atrophy in neuromyelitis optica spectrum disordersMultiple Sclerosis and Related Disorders, 2016
- Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesAnnals of Neurology, 2015
- Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry studyEuropean Journal of Radiology, 2012
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007